88R11662 LRM-F
 
  By: Raymond H.B. No. 4288
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to a study on the use of alternative therapies for treating
  post-traumatic stress disorder.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Sections 1(b), (c), (d), and (f), Chapter 983
  (H.B. 1802), Acts of the 87th Legislature, Regular Session, 2021,
  are amended to read as follows:
         (b)  The commission, in collaboration with Baylor College of
  Medicine and in partnership with a military veterans hospital, [or]
  a medical center that provides medical care to veterans, or a
  facility licensed in this state that provides Ketamine-related
  mental health services, shall conduct a study on the efficacy of
  using alternative therapies, including the use of
  3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and
  ketamine, in the treatment of veterans and other identified
  individuals who suffer from post-traumatic stress disorder.
         (c)  In conducting the study described by Subsection (b) of
  this section, the commission in collaboration with the Baylor
  College of Medicine shall:
               (1)  perform a clinical trial on the therapeutic
  efficacy of using psilocybin in the treatment of
  treatment-resistant post-traumatic stress disorder in veterans and
  other identified individuals; [and]
               (2)  prescribe standardized protocols for each
  researcher or research organization participating in the study; and
               (3)  review current literature regarding:
                     (A)  the safety and efficacy of
  3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and
  ketamine in the treatment of post-traumatic stress disorder; and
                     (B)  the access veterans and other identified
  individuals have to 3,4-methylenedioxymethamphetamine (MDMA),
  psilocybin, and ketamine for treatment of post-traumatic stress
  disorder in the United States.
         (d)  The commission shall prepare and submit to the governor,
  the lieutenant governor, the speaker of the house of
  representatives, and each member of the legislature:
               (1)  quarterly reports on the progress of the study
  conducted under this section; and
               (2)  not later than December 1, 2026 [2024], a written
  report containing the results of the study conducted under this
  section and any recommendations for legislative or other action.
         (f)  This Act expires September 1, 2027 [2025].
         SECTION 2.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2023.